社区中的耐多药细菌：最新进展。
Multidrug-Resistant Bacteria in the Community: An Update.
机构信息
Division of Infectious Diseases, University of North Carolina, CB 7030, 130 Mason Farm Road, Chapel Hill, NC 27599, USA.
University of Queensland Centre for Clinical Research, Royal Brisbane & Women's Hospital Campus, Building 71/918, Herston, Queensland 4029, Australia.
出版信息
Infect Dis Clin North Am. 2020 Dec;34(4):709-722. doi: 10.1016/j.idc.2020.08.002. Epub 2020 Sep 30.
Abstract
Multidrug-resistant bacteria are among the most important current threats to public health. Typically, they are associated with nosocomial infections. However, some have become prevalent causes of community-acquired infections, such as Neisseria gonorrhoeae, Shigella, Salmonella, and Streptococcus pneumoniae. The community spread of multidrug-resistant bacteria is also a crucial development. An important global threat on the horizon is represented by production of carbapenemases by community-acquired hypervirulent Klebsiella pneumoniae. Such strains have already been found in Asia, Europe, and North America. Prevention of further community spread of multidrug-resistant bacteria is of the utmost importance, and will require a multidisciplinary approach involving all stakeholders.
摘要
耐多药细菌是当前对公众健康最重要的威胁之一。它们通常与医院获得性感染有关。然而，一些耐多药细菌已经成为社区获得性感染的常见原因，如淋病奈瑟菌、志贺氏菌、沙门氏菌和肺炎链球菌。耐多药细菌的社区传播也是一个关键的发展。社区获得性高毒力肺炎克雷伯菌产生碳青霉烯酶是一个重要的全球性威胁。这种菌株已经在亚洲、欧洲和北美发现。防止耐多药细菌进一步在社区传播至关重要，这将需要一个涉及所有利益相关者的多学科方法。
相似文献
1
Multidrug-Resistant Bacteria in the Community: An Update.社区中的耐多药细菌：最新进展。
Infect Dis Clin North Am. 2020 Dec;34(4):709-722. doi: 10.1016/j.idc.2020.08.002. Epub 2020 Sep 30.
2
Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.社区中的多重耐药细菌：趋势与经验教训
Infect Dis Clin North Am. 2016 Jun;30(2):377-390. doi: 10.1016/j.idc.2016.02.004.
3
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.中国腹腔感染患者大肠埃希菌和肺炎克雷伯菌分离株的发病率及抗菌药物敏感性趋势更新
BMC Infect Dis. 2017 Dec 18;17(1):776. doi: 10.1186/s12879-017-2873-z.
4
Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA.采用微生物检测方法，对肯尼亚糖尿病足溃疡患者进行细菌分离及抗生素敏感性检测，并与逆转录聚合酶链反应（RT-PCR）检测金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌（MRSA）的结果进行比较。
BMC Res Notes. 2019 Apr 29;12(1):244. doi: 10.1186/s13104-019-4278-0.
5
Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017.瑞士养老院的抗生素耐药性：2007 年至 2017 年期间 11 年国家监测数据的分析。
Antimicrob Resist Infect Control. 2018 Jul 20;7:88. doi: 10.1186/s13756-018-0378-1. eCollection 2018.
6
[Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].[2011年、2013年和2016年医院获得性菌血症病原菌的微生物学特征]
Sheng Wu Gong Cheng Xue Bao. 2018 Aug 25;34(8):1205-1217. doi: 10.13345/j.cjb.180192.
7
[High prevalence of community- and hospital-acquired infections of methicillin-resistant Staphylococcus aureus containing Panton-Valentine leukocidin gene in Algiers].[阿尔及尔社区获得性和医院获得性含杀白细胞素基因的耐甲氧西林金黄色葡萄球菌感染的高患病率]
Pathol Biol (Paris). 2010 Apr;58(2):e15-20. doi: 10.1016/j.patbio.2009.07.017. Epub 2009 Oct 28.
8
Clinical characteristics of patients with pneumonia caused by in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study.台湾地区肺炎克雷伯菌感染患者的临床特征和抗菌药物耐药及强毒力株的流行情况：一项回顾性研究。
Antimicrob Resist Infect Control. 2020 Jan 3;9(1):4. doi: 10.1186/s13756-019-0660-x. eCollection 2020.
9
High prevalence of t895 and t9364 spa types of methicillin-resistant Staphylococcus aureus in a tertiary-care hospital in Mexico: different lineages of clonal complex 5.耐甲氧西林金黄色葡萄球菌 t895 和 t9364 spa 型在墨西哥一家三级保健医院的高流行率：克隆复合体 5 的不同谱系。
BMC Microbiol. 2020 Jul 20;20(1):213. doi: 10.1186/s12866-020-01881-w.
10
Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003-2014).尿路感染患者分离出的大肠杆菌和肺炎克雷伯菌中抗生素多重耐药性的演变：一项为期12年的分析（2003 - 2014年）
Enferm Infecc Microbiol Clin. 2017 May;35(5):293-298. doi: 10.1016/j.eimc.2016.02.018. Epub 2016 Apr 5.
引用本文的文献
1
Design of Miniprotein Inhibitors of Bacterial Adhesins.细菌粘附素微型蛋白抑制剂的设计
bioRxiv. 2025 Aug 18:2025.08.18.670751. doi: 10.1101/2025.08.18.670751.
2
Lessons from Four Years (2021-2024) of Resistance Surveillance Epidemiological Trends in a Romanian Intensive Care Unit.罗马尼亚重症监护病房四年（2021 - 2024年）耐药监测流行病学趋势的经验教训
Antibiotics (Basel). 2025 Aug 12;14(8):825. doi: 10.3390/antibiotics14080825.
3
Proteomic Insights into Bacterial Responses to Antibiotics: A Narrative Review.蛋白质组学对细菌抗生素反应的见解：一篇综述
Int J Mol Sci. 2025 Jul 27;26(15):7255. doi: 10.3390/ijms26157255.
4
Resistome and Phylogenomics of Strains Obtained from Diverse Sources in Jimma, Ethiopia.埃塞俄比亚吉马不同来源菌株的抗性组与系统发育基因组学
Antibiotics (Basel). 2025 Jul 14;14(7):706. doi: 10.3390/antibiotics14070706.
5
Therapeutic efficacy of different sulperazon dosing regimens in carbapenem-resistant Klebsiella pneumoniae: a retrospective analysis of 209 cases.不同舒普深给药方案治疗耐碳青霉烯类肺炎克雷伯菌的疗效：209例回顾性分析
Am J Transl Res. 2025 Jun 15;17(6):4764-4773. doi: 10.62347/TZFB9853. eCollection 2025.
6
The challenge of multidrug resistance in hospitalized pediatric patients with urinary tract infections.住院小儿尿路感染患者多重耐药的挑战。
Front Cell Infect Microbiol. 2025 Jul 1;15:1570405. doi: 10.3389/fcimb.2025.1570405. eCollection 2025.
7
Syndemics of Antimicrobial Resistance: Non-communicable Diseases, Social Deprivation, and the Rise of Multidrug-Resistant Infections.抗菌药物耐药性综合征：非传染性疾病、社会剥夺与多重耐药感染的兴起
Infect Dis Ther. 2025 Jul 3. doi: 10.1007/s40121-025-01188-1.
8
Broad-spectrum antimicrobial activity and efficacy of SK1260 against bacterial pathogens.SK1260对细菌病原体的广谱抗菌活性和疗效。
Front Microbiol. 2025 Apr 10;16:1553693. doi: 10.3389/fmicb.2025.1553693. eCollection 2025.
9
Meropenem-Vaborbactam for Treatment of Carbapenem-Resistant Enterobacterales: A Narrative Review of Clinical Practice Evidence.美罗培南-巴坦治疗耐碳青霉烯类肠杆菌科细菌感染：临床实践证据的叙述性综述
Infect Dis Ther. 2025 May;14(5):973-989. doi: 10.1007/s40121-025-01146-x. Epub 2025 Apr 12.
10
Anti-biofilm and anti-quorum sensing activities of galloylquinic acid against clinical isolates of multidrug-resistant Pseudomonas aeruginosa in open wound infection: in vitro and in vivo efficacy studies.没食子酰奎宁酸对开放性伤口感染中多药耐药铜绿假单胞菌临床分离株的抗生物膜和抗群体感应活性：体内外疗效研究
BMC Microbiol. 2025 Apr 9;25(1):206. doi: 10.1186/s12866-024-03712-8.
本文引用的文献
1
Unlikely Bedfellows: The Partnering of Antibiotic Stewardship Programs and the Pharmaceutical Industry.unlikely伙伴：抗生素管理计划与制药行业的合作
Clin Infect Dis. 2020 Jul 27;71(3):682-684. doi: 10.1093/cid/ciaa056.
2
Extensively Drug-Resistant Shigellosis in Australia among Men Who Have Sex with Men.澳大利亚男男性行为者中的广泛耐药志贺菌病
N Engl J Med. 2019 Dec 19;381(25):2477-2479. doi: 10.1056/NEJMc1910648.
3
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia.目前针对头孢曲松耐药的革兰氏阴性菌血症的治疗证据。
Curr Opin Infect Dis. 2020 Feb;33(1):78-85. doi: 10.1097/QCO.0000000000000623.
4
Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.中国碳青霉烯类耐药肺炎克雷伯菌高毒力进化：一项多中心、分子流行病学分析。
J Antimicrob Chemother. 2020 Feb 1;75(2):327-336. doi: 10.1093/jac/dkz446.
5
Identification of a Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae Isolate in the United States.鉴定美国产高产毒碳青霉烯酶肺炎克雷伯菌。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00519-19. Print 2019 Jul.
6
Whole genome assembly and functional portrait of hypervirulent extensively drug-resistant NDM-1 and KPC-2 co-producing Klebsiella pneumoniae of capsular serotype K2 and ST86.携带NDM-1和KPC-2的高毒力、广泛耐药、产荚膜血清型K2和ST86的肺炎克雷伯菌的全基因组组装及功能图谱
J Antimicrob Chemother. 2019 May 1;74(5):1233-1240. doi: 10.1093/jac/dkz023.
7
New antibiotics for community-acquired pneumonia.用于社区获得性肺炎的新型抗生素。
Curr Opin Infect Dis. 2019 Apr;32(2):169-175. doi: 10.1097/QCO.0000000000000526.
8
A case of NDM-carbapenemase-producing hypervirulent sequence type 23 from the UK.来自英国的一例产NDM-碳青霉烯酶的高毒力序列型23菌株。
JMM Case Rep. 2018 May 17;5(9):e005130. doi: 10.1099/jmmcr.0.005130. eCollection 2018 Sep.
9
Genome-Based Prediction of Bacterial Antibiotic Resistance.基于基因组的细菌抗生素耐药性预测。
J Clin Microbiol. 2019 Feb 27;57(3). doi: 10.1128/JCM.01405-18. Print 2019 Mar.
10
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.哌拉西林-他唑巴坦与美罗培南对产 ESBLs 的大肠埃希菌或肺炎克雷伯菌血流感染且对头孢曲松耐药患者 30 天死亡率的影响：一项随机临床试验。
JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163.
Zotero 插件